1. CMU Intellectual Repository

Browsing by Author Tim R. Cressey

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 69 to 88 of 108 < previous   next >
Issue DateTitleAuthor(s)
1-Jan-2015Pharmacokinetics of vancomycin in critically ill patients in ThailandThitinat Dedkaew; Tim R. Cressey; Baralee Punyawudho; Aroonrut Lucksiri
1-Jan-2013Pharmacological assessment of efavirenz weight-band dosing recommendations in HIV-infected thai childrenTim R. Cressey; Linda Aurpibul; Thition Narkbunnam; Virat Sirisanthana; Wanatpreeya Phongsamart; Peninnah Oberdorfer; Keswadee Lapphra; Tavitiya Sudjaritruk; Kulkanya Chokephaibulkit
1-Feb-2018A phase II/III trial of lopinavir/ritonavir dosed according to the WHO pediatric weight band dosing guidelinesJorge A. Pinto; Edmund V. Capparelli; Meredith Warshaw; Bonnie Zimmer; Tim R. Cressey; Stephen A. Spector; Min Qin; Betsy Smith; George K. Siberry; Mark Mirochnick
1-Jun-2021Physiologically Based Pharmacokinetic Modeling Framework to Predict Neonatal Pharmacokinetics of Transplacentally Acquired Emtricitabine, Dolutegravir, and RaltegravirXiaomei I. Liu; Jeremiah D. Momper; Natella Y. Rakhmanina; Dionna J. Green; Gilbert J. Burckart; Tim R. Cressey; Mark Mirochnick; Brookie M. Best; John N. van den Anker; André Dallmann
1-Dec-2021Pilot evaluation of an enzymatic assay for rapid measurement of antiretroviral drug concentrationsAyokunle O. Olanrewaju; Benjamin P. Sullivan; Ashley R. Bardon; Tiffany J. Lo; Tim R. Cressey; Jonathan D. Posner; Paul K. Drain
1-Jan-2015Plasma and Intracellular Pharmacokinetics of Tenofovir Disoproxil Fumarate 300 mg Every 48 Hours vs 150 mg Once Daily in HIV-Infected Adults with Moderate Renal Function ImpairmentTim R. Cressey; Anchalee Avihingsanon; Guttiga Halue; Prattana Leenasirimakul; Pra Ornsuda Sukrakanchana; Yardpiroon Tawon; Nirattiya Jaisieng; Gonzague Jourdain; Anthony T. Podany; Courtney V. Fletcher; Virat Klinbuayaem; Chureeratana Bowonwatanuwong
15-May-2008Plasma drug concentrations and virologic evaluations after stopping treatment with nonnucleoside reverse-transcriptase inhibitors in HIV type 1-infected childrenTim R. Cressey; Hannah Green; Saye Khoo; Jean Marc Treluyer; Alexandra Compagnucci; Yacine Saidi; Marc Lallemant; Diana M. Gibb; David M. Burger
29-Jun-2009Plasma efavirenz concentrations and the association with CYP2B6-516G&gt;T polymorphism in HIV-infected Thai ChildrenThanyawee Puthanakit; Pranoot Tanpaiboom; Linda Aurpibul; Tim R. Cressey; Virat Sirisanthana
1-Aug-2020Plasma pharmacokinetics and urinary excretion of tenofovir following cessation in adults with controlled levels of adherence to tenofovir disoproxil fumarateTim R. Cressey; Oraphan Siriprakaisil; Rachel W. Kubiak; Virat Klinbuayaem; Pra ornsuda Sukrakanchana; Justice Quame-Amaglo; Hideaki Okochi; Yardpiroon Tawon; Ratchada Cressey; Jared M. Baeten; Monica Gandhi; Paul K. Drain
1-Oct-2020Point-of-care and Near Real-time Testing for Antiretroviral Adherence Monitoring to HIV Treatment and PreventionPaul K. Drain; Ashley R. Bardon; Jane M. Simoni; Tim R. Cressey; Pete Anderson; Derin Sevenler; Ayokunle O. Olanrewaju; Monica Gandhi; Connie Celum
1-Apr-2022Point-of-care semi-quantitative test for adherence to tenofovir alafenamide or tenofovir disoproxil fumarateDerin Sevenler; Xin Niu; Sandy Dossantos; Mehmet Toner; Tim R. Cressey; Rebecca D. Sandlin; Paul K. Drain
1-Jan-2016A Population Pharmacokinetic/Pharmacodynamic Model Predicts Favorable HDL Cholesterol Changes Over the First 5 Years in Children Treated With Current Efavirenz-Based RegimensNontiya Homkham; Tim R. Cressey; Lily Ingsrisawang; Naïm Bouazza; Chaiwat Ngampiyaskul; Suchat Hongsiriwon; Sakulrat Srirojana; Suparat Kanjanavanit; Sorakij Bhakeecheep; Sophie Le Coeur; Nicolas Salvadori; Jean Marc Treluyer; Gonzague Jourdain; Saik Urien
1-Mar-2021Population pharmacokinetics of tenofovir in pregnant and postpartum women using tenofovir disoproxil fumarateAhizechukwu C. Eke; Kensuke Shoji; Brookie M. Best; Jeremiah D. Momper; Alice M. Stek; Tim R. Cressey; Mark Mirochnick; Edmund V. Capparelli
1-Oct-2012Potential effect of pharmacogenetics on maternal, fetal and infant antiretroviral drug exposure during pregnancy and breastfeedingAdeniyi Olagunju; Andrew Owen; Tim R. Cressey
1-Jan-2020Prediction of Maternal and Fetal Pharmacokinetics of Dolutegravir and Raltegravir Using Physiologically Based Pharmacokinetic ModelingXiaomei I. Liu; Jeremiah D. Momper; Natella Y. Rakhmanina; Dionna J. Green; Gilbert J. Burckart; Tim R. Cressey; Mark Mirochnick; Brookie M. Best; John N. van den Anker; André Dallmann
1-May-2012Predictors of 5-year mortality in HIV-infected adults starting highly active antiretroviral therapy in ThailandFederica Fregonese; Intira J. Collins; Gonzague Jourdain; Sophie LeCoeur; Tim R. Cressey; Nicole Ngo-Giang-Houng; Sukit Banchongkit; Apichat Chutanunta; Malee Techapornroong; Marc Lallemant
2-Jan-2018Prevention and treatment of HIV infection in neonates: evidence base for existing WHO dosing recommendations and implementation considerationsDiana F. Clarke; Martina Penazzato; Edmund Capparelli; Tim R. Cressey; George Siberry; Nandita Sugandhi; Mark Mirochnick
9-Aug-2016Prevention of mother-to-child transmission of hepatitis B virus: A phase III, placebo-controlled, double-blind, randomized clinical trial to assess the efficacy and safety of a short course of tenofovir disoproxil fumarate in women with hepatitis B virus e-antigenGonzague Jourdain; Nicole Ngo-Giang-Huong; Tim R. Cressey; Lei Hua; Linda Harrison; Camlin Tierney; Nicolas Salvadori; Luc Decker; Patrinee Traisathit; Wasna Sirirungsi; Woottichai Khamduang; Chureeratana Bowonwatanuwong; Thanyawee Puthanakit; George K. Siberry; Diane Heather Watts; Trudy V. Murphy; Jullapong Achalapong; Suchat Hongsiriwon; Virat Klinbuayaem; Satawat Thongsawat; Raymond T. Chung; Stanislas Pol; Nantasak Chotivanich
1-Sep-2019Prioritising the most needed paediatric antiretroviral formulations: the PADO4 listMartina Penazzato; Claire L. Townsend; Natella Rakhmanina; Yao Cheng; Moherndran Archary; Tim R. Cressey; Maria H. Kim; Victor Musiime; Anna Turkova; Theodore D. Ruel; Helena Rabie; Nandita Sugandhi; Pablo Rojo; Meg Doherty; Elaine J. Abrams; Elaine Abrams; Jintanat Ananworanich; Isabelle Andrieux-Meyer; Yodit Belew; Brookie Best; Rosa Bologna; Jessica Burry; Deborah Carpenter; Polly Clayden; Angela Colbers; Magda Conway; Timothy R. Cressey; Mutsa Dangarembizi; Shaffiq Essajee; Maribel Gonzalez Tome; Andrew Hill; Saye Khoo; Maria Kim; Linda Lewis; Janice Lee; Shahin Lockman; Imelda Mahaka; Mark H. Mirochnick; Lynne Mofenson; Mireille Muhimpundu; Angela Mushavi; Elizabeth Obimbo; Fernando Pascual; Carmen Perez Casas; Anton Pozniak; Theodore Ruel; Jonathan Schapiro; George Siberry; Teresa Beatriz Simione; Cheick Tidiane Tall; Francois Venter; Marissa Vicari; Jenny Walsh; Jacque Wambui; Melynda Watkins
1-Jan-2014Raltegravir pharmacokinetics during pregnancyD. Heather Watts; Alice Stek; Brookie M. Best; Jiajia Wang; Edmund V. Capparelli; Tim R. Cressey; Francesca Aweeka; Patty Lizak; Regis Kreitchmann; Sandra K. Burchett; David E. Shapiro; Elizabeth Hawkins; Elizabeth Smith; Mark Mirochnick
Showing results 69 to 88 of 108 < previous   next >